JRCT ID: jRCT1051240060
Registered date:11/06/2024
Study on effectiveness and convalescence prediction factor of the cure for the progress hepatocellular carcinoma
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | hepatocellular carcinoma |
| Date of first enrollment | 11/06/2024 |
| Target sample size | 500 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | overall survivals |
|---|---|
| Secondary Outcome | Tumor shrinkage effect Side effects Blood tests: CBC, prothrombin time, various blood biochemistry (AST, ALT, ALP, gamma-GTP, T-Bil, Alb, Cre, BUN, CRP), tumor markers (AFP(L3), PIVKA-II) Performancs status Progression free survival |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | The patient who performed radio wave cautery therapy, hepatic artery embolus therapy, hepatic artery intraarterial injection therapy, chemotherapy for a hepatocellular carcinoma on after January 1, 2015 |
| Exclude criteria | The patient who was able to confirm a declaration of intention of the participation refusal |
Related Information
| Primary Sponsor | Nishimura Naoki |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Naoki Nishimura |
| Address | 840 Shijo-Cho, Kashihara, Nara, Japan Nara Japan 634-8521 |
| Telephone | +81-745-22-3051 |
| na0k1nnn@yahoo.co.jp | |
| Affiliation | Nara Medical University |
| Scientific contact | |
| Name | Naoki Nishimura |
| Address | 840 Shijo-Cho, Kashihara, Nara, Japan Nara Japan 634-8521 |
| Telephone | +81-745-22-3051 |
| K147051@naramed-u.ac.jp | |
| Affiliation | Nara Medical University |